Evolution Wealth Advisors LLC Has $2.86 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Evolution Wealth Advisors LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 0.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 21,058 shares of the financial services provider’s stock after selling 105 shares during the period. Evolution Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,861,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in IBB. Moneta Group Investment Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 131,598.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after buying an additional 4,466,451 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of iShares Biotechnology ETF by 159.9% during the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock valued at $253,975,000 after buying an additional 1,209,700 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $76,425,000. Goldman Sachs Group Inc. boosted its stake in shares of iShares Biotechnology ETF by 49.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock valued at $204,332,000 after buying an additional 521,820 shares during the period. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at $48,242,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1 %

Shares of NASDAQ:IBB traded up $0.08 during trading on Friday, reaching $124.72. 1,996,759 shares of the company traded hands, compared to its average volume of 1,810,208. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The firm has a fifty day simple moving average of $135.09 and a 200 day simple moving average of $129.54. The firm has a market cap of $6.93 billion, a P/E ratio of 16.28 and a beta of 0.84.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.